Cargando…

A meta-analysis for vaccine protection rate of duck hepatitis a virus in mainland China in 2009–2021

BACKGROUND: Duck hepatitis A virus (DHAV) is a single-stranded, positive-strand small RNA virus that causes a very high mortality rate in ducklings. The DHAV-3 subtype incidence rate has recently increased in China, causing great economic losses to the waterfowl breeding industry. We analyzed the pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Lina, Zhou, Siyu, Zhang, Huiling, Zhang, Tangjie, Yang, Daiqi, Hong, Xingping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540391/
https://www.ncbi.nlm.nih.gov/pubmed/37773135
http://dx.doi.org/10.1186/s12917-023-03744-8
_version_ 1785113706453008384
author Ye, Lina
Zhou, Siyu
Zhang, Huiling
Zhang, Tangjie
Yang, Daiqi
Hong, Xingping
author_facet Ye, Lina
Zhou, Siyu
Zhang, Huiling
Zhang, Tangjie
Yang, Daiqi
Hong, Xingping
author_sort Ye, Lina
collection PubMed
description BACKGROUND: Duck hepatitis A virus (DHAV) is a single-stranded, positive-strand small RNA virus that causes a very high mortality rate in ducklings. The DHAV-3 subtype incidence rate has recently increased in China, causing great economic losses to the waterfowl breeding industry. We analyzed the protection rate of DHAV vaccines used in mainland China from 2009 to 2021 and evaluated the effectiveness of vaccine prevention and control to reduce the economic losses caused by DHAV to the waterfowl breeding industry. We screened five electronic research databases and obtained 14 studies and patents on the protection efficiency of DHAV-1 and DHAV-3 vaccines. RESULTS: Meta-analysis demonstrated that immunized ducklings produced higher antibody levels and had a significantly higher survival rate than non-immunized ducklings [relative risk (RR) = 12, 95% confidence interval (CI) 6–26, P < 0.01]. The age of the ducks and vaccine valence did not affect protection efficiency. Data source analysis of the vaccine protection rate demonstrated that the vaccines conferred immune protection for ducklings in both small-scale experiments and large-scale clinical conditions. The analysis results revealed that although the vaccines conferred protection, the immune protective effect differed between small-scale experimental conditions and large-scale clinical conditions. This might have been due to non-standard vaccination and environmental factors. CONCLUSIONS: Domestic DHAV vaccines can protect ducklings effectively. The subjects immunized (breeding ducks or ducklings) and vaccine valence had no effect on the protective effect. Both small-scale experiments and large-scale clinical conditions conferred immune protection on ducklings, but vaccine immunization under small-scale experimental conditions had slightly better protective effects than large-scale clinical immunization. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12917-023-03744-8.
format Online
Article
Text
id pubmed-10540391
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105403912023-09-30 A meta-analysis for vaccine protection rate of duck hepatitis a virus in mainland China in 2009–2021 Ye, Lina Zhou, Siyu Zhang, Huiling Zhang, Tangjie Yang, Daiqi Hong, Xingping BMC Vet Res Research BACKGROUND: Duck hepatitis A virus (DHAV) is a single-stranded, positive-strand small RNA virus that causes a very high mortality rate in ducklings. The DHAV-3 subtype incidence rate has recently increased in China, causing great economic losses to the waterfowl breeding industry. We analyzed the protection rate of DHAV vaccines used in mainland China from 2009 to 2021 and evaluated the effectiveness of vaccine prevention and control to reduce the economic losses caused by DHAV to the waterfowl breeding industry. We screened five electronic research databases and obtained 14 studies and patents on the protection efficiency of DHAV-1 and DHAV-3 vaccines. RESULTS: Meta-analysis demonstrated that immunized ducklings produced higher antibody levels and had a significantly higher survival rate than non-immunized ducklings [relative risk (RR) = 12, 95% confidence interval (CI) 6–26, P < 0.01]. The age of the ducks and vaccine valence did not affect protection efficiency. Data source analysis of the vaccine protection rate demonstrated that the vaccines conferred immune protection for ducklings in both small-scale experiments and large-scale clinical conditions. The analysis results revealed that although the vaccines conferred protection, the immune protective effect differed between small-scale experimental conditions and large-scale clinical conditions. This might have been due to non-standard vaccination and environmental factors. CONCLUSIONS: Domestic DHAV vaccines can protect ducklings effectively. The subjects immunized (breeding ducks or ducklings) and vaccine valence had no effect on the protective effect. Both small-scale experiments and large-scale clinical conditions conferred immune protection on ducklings, but vaccine immunization under small-scale experimental conditions had slightly better protective effects than large-scale clinical immunization. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12917-023-03744-8. BioMed Central 2023-09-29 /pmc/articles/PMC10540391/ /pubmed/37773135 http://dx.doi.org/10.1186/s12917-023-03744-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ye, Lina
Zhou, Siyu
Zhang, Huiling
Zhang, Tangjie
Yang, Daiqi
Hong, Xingping
A meta-analysis for vaccine protection rate of duck hepatitis a virus in mainland China in 2009–2021
title A meta-analysis for vaccine protection rate of duck hepatitis a virus in mainland China in 2009–2021
title_full A meta-analysis for vaccine protection rate of duck hepatitis a virus in mainland China in 2009–2021
title_fullStr A meta-analysis for vaccine protection rate of duck hepatitis a virus in mainland China in 2009–2021
title_full_unstemmed A meta-analysis for vaccine protection rate of duck hepatitis a virus in mainland China in 2009–2021
title_short A meta-analysis for vaccine protection rate of duck hepatitis a virus in mainland China in 2009–2021
title_sort meta-analysis for vaccine protection rate of duck hepatitis a virus in mainland china in 2009–2021
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540391/
https://www.ncbi.nlm.nih.gov/pubmed/37773135
http://dx.doi.org/10.1186/s12917-023-03744-8
work_keys_str_mv AT yelina ametaanalysisforvaccineprotectionrateofduckhepatitisavirusinmainlandchinain20092021
AT zhousiyu ametaanalysisforvaccineprotectionrateofduckhepatitisavirusinmainlandchinain20092021
AT zhanghuiling ametaanalysisforvaccineprotectionrateofduckhepatitisavirusinmainlandchinain20092021
AT zhangtangjie ametaanalysisforvaccineprotectionrateofduckhepatitisavirusinmainlandchinain20092021
AT yangdaiqi ametaanalysisforvaccineprotectionrateofduckhepatitisavirusinmainlandchinain20092021
AT hongxingping ametaanalysisforvaccineprotectionrateofduckhepatitisavirusinmainlandchinain20092021
AT yelina metaanalysisforvaccineprotectionrateofduckhepatitisavirusinmainlandchinain20092021
AT zhousiyu metaanalysisforvaccineprotectionrateofduckhepatitisavirusinmainlandchinain20092021
AT zhanghuiling metaanalysisforvaccineprotectionrateofduckhepatitisavirusinmainlandchinain20092021
AT zhangtangjie metaanalysisforvaccineprotectionrateofduckhepatitisavirusinmainlandchinain20092021
AT yangdaiqi metaanalysisforvaccineprotectionrateofduckhepatitisavirusinmainlandchinain20092021
AT hongxingping metaanalysisforvaccineprotectionrateofduckhepatitisavirusinmainlandchinain20092021